1. Home
  2. HTGC vs JANX Comparison

HTGC vs JANX Comparison

Compare HTGC & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTGC
  • JANX
  • Stock Information
  • Founded
  • HTGC 2003
  • JANX 2017
  • Country
  • HTGC United States
  • JANX United States
  • Employees
  • HTGC N/A
  • JANX N/A
  • Industry
  • HTGC Investment Managers
  • JANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTGC Finance
  • JANX Health Care
  • Exchange
  • HTGC Nasdaq
  • JANX Nasdaq
  • Market Cap
  • HTGC 3.2B
  • JANX 2.9B
  • IPO Year
  • HTGC 2005
  • JANX 2021
  • Fundamental
  • Price
  • HTGC $18.77
  • JANX $50.31
  • Analyst Decision
  • HTGC Buy
  • JANX Strong Buy
  • Analyst Count
  • HTGC 8
  • JANX 11
  • Target Price
  • HTGC $19.38
  • JANX $66.36
  • AVG Volume (30 Days)
  • HTGC 1.3M
  • JANX 635.6K
  • Earning Date
  • HTGC 10-30-2024
  • JANX 11-06-2024
  • Dividend Yield
  • HTGC 8.53%
  • JANX N/A
  • EPS Growth
  • HTGC 1.34
  • JANX N/A
  • EPS
  • HTGC 2.01
  • JANX N/A
  • Revenue
  • HTGC $494,410,000.00
  • JANX $13,049,000.00
  • Revenue This Year
  • HTGC $11.06
  • JANX $66.30
  • Revenue Next Year
  • HTGC $5.70
  • JANX N/A
  • P/E Ratio
  • HTGC $9.33
  • JANX N/A
  • Revenue Growth
  • HTGC 12.81
  • JANX 54.12
  • 52 Week Low
  • HTGC $15.14
  • JANX $7.79
  • 52 Week High
  • HTGC $21.78
  • JANX $65.60
  • Technical
  • Relative Strength Index (RSI)
  • HTGC 39.01
  • JANX 48.44
  • Support Level
  • HTGC $18.51
  • JANX $45.95
  • Resistance Level
  • HTGC $19.24
  • JANX $49.74
  • Average True Range (ATR)
  • HTGC 0.38
  • JANX 2.80
  • MACD
  • HTGC -0.09
  • JANX -0.77
  • Stochastic Oscillator
  • HTGC 16.45
  • JANX 37.81

About HTGC Hercules Capital Inc.

Hercules Capital Inc is a specialty finance company engaged in providing senior secured loans to high-growth, venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.

Share on Social Networks: